Granite Point Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Granite Point Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-53,000	Closed	-$1.75M	–	122
2017 Q3	$1.75M	Sell	53,000 -5,600	-10%	-$194K	0.37%	34
2017 Q2	$1.96M	Buy	+58,600	New	+$1.75M	0.48%	35
2017 Q1	–	Sell	-49,746	Closed	-$1.11M	–	114
2016 Q4	$1.11M	Hold	49,746	–	–	0.89%	37
2016 Q3	$924K	Sell	49,746 -11,525	-19%	-$217K	0.36%	47
2016 Q2	$999K	Buy	+61,271	New	+$901K	0.43%	42
2015 Q4	$1.26M	Sell	108,000 -12,000	-10%	-$152K	0.19%	32
2015 Q3	$1.47M	Sell	120,000 -81,832	-41%	-$1.04M	1.01%	21
2015 Q2	$1.9M	Sell	201,832 -48,168	-19%	-$446K	0.55%	20
2015 Q1	$2.21M	Buy	250,000 +25,000	+11%	+$253K	0.81%	23
2014 Q4	$2.26M	Sell	225,000 -25,000	-10%	-$214K	1.06%	18
2014 Q3	$1.68M	Buy	250,000 +90,000	+56%	+$631K	0.84%	21
2014 Q2	$1.15M	Sell	160,000 -40,000	-20%	-$318K	0.79%	24
2014 Q1	$2.02M	Buy	200,000 +100,000	+100%	+$920K	1.44%	17
2013 Q4	$794K	Buy	+100,000	New	+$933K	0.13%	73

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Granite Point Capital Management's BEAT Position: Q4 2017 in Review

Granite Point Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 53,000 shares — an estimated $1.75M sold.

Granite Point Capital Management first reported a position in BEAT in Q4 2013 and held it in 14 quarters. The position peaked at $2.26M in Q4 2014. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

Granite Point Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
Granite Point Capital Management sold 53,000 BioTelemetry, Inc. shares in Q4 2017, an estimated $1.75M.
Granite Point Capital Management first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 14 quarters.
Granite Point Capital Management's BioTelemetry, Inc. position peaked at $2.26M in Q4 2014.
192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.